Background: The clinical importance of ovarian teratoma in anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis has been established, however investigations of ovarian teratoma in patients with anti-NMDAR encephalitis remain limited. Objective: To clarify differences in NMDAR distribution and lymphocyte infiltration in ovarian teratoma between patients with and without anti-NMDAR encephalitis. Methods: Participants initially comprised 26 patients with ovarian teratomas. NMDAR distribution and lymphocyte infiltration in ovarian teratomas were examined using immunopathological techniques. Clinical, laboratory, and radiological data were compared between patients showing the features of encephalitis. Anti-NMDAR antibodies in the serum and cerebrospinal fluid were also measured in encephalitis patients. Results: Neuronal tissues were obtained from ovarian teratomas in 22 patients (after excluding 4 patients who did not satisfy the inclusion criteria), and the presence of NMDA receptor subunits was revealed in all patients. Lymphocyte infiltration was more frequent in the encephalitis group (n = 3) than in the non-encephalitis group. In particular, dense B-lymphocyte infiltration near neural tissues was observed in the encephalitis group. Conclusions: Differences in lymphocyte infiltration in ovarian teratomas between anti-NMDAR encephalitis and non-encephalitis patients suggest the immunological importance of the ovarian teratoma as the site of antigen presentation in anti-NMDAR encephalitis.

1.
Dalmau J, Lancaster E, Martinez-Hernandez E: Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
2.
Dalmau J, Tüzün E, Wu HY: Paraneoplastic N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
3.
Benarroch EE: NMDA receptors: recent insights and clinical correlations. Neurology 2011;76:1750-1757.
4.
Iizuka T, Sakai F, Ide T: Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008;70:504-511.
5.
Dalmau J, Gleichman AJ, Hughes EG: Anti-NMDA receptor encephalitis: case series and analysis of effects of antibodies. Lancet Neurol 2008;7:1091-1098.
6.
Takahashi Y, Mogami Y, Takayama R: Antibodies to glutamate receptor in limbic encephalitis. Brain Nerve 2010;62:827-837.
7.
Uchino A, Iizuka T, Urano Y: Pseudo-piano playing motions and nocturnal hypoventilation in anti-NMDA receptor encephalitis: response to prompt tumor removal and immunotherapy. Intern Med 2011;50:627-630.
8.
Zhang Q, Tanaka K, Sun P: Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients. Neurobiol Dis 2012;45:610-615.
9.
Seki M, Suzuki S, Iizuka T: Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry 2008;79:324-326.
10.
Vitaliani R, Mason W, Ances B: Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005;58:594-604.
11.
Kleyensteuber B, Ruterbusch V, Bennett J: Limbic encephalitis presenting with seizures, anterograde amnesia, and psychosis in a patient seven weeks status post immature ovarian teratoma removal. Mil Med 2010;175:616-618.
12.
Lo JW, Leung EY, Ng BL: Anti-N-methyl-D-aspartate receptor encephalitis in a young woman with an ovarian tumour. Hong Kong Med J 2010;16:313-316.
13.
Sonn TS, Merritt DF: Anti-NMDA receptor encephalitis: an adolescent with an ovarian teratoma. J Pediatr Adolesc Gynecol 2010;23:e141-e144.
14.
Tüzün E, Zhou L, Baehring JM: Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 2009;118:737-743.
15.
Kataoka H, Dalmau J, Ueno S: Paraneoplastic encephalitis associated with ovarian teratoma and N-methyl-D-aspartate receptor antibodies. Eur J Neurol 2008;15:e5-e6.
16.
Trojanowski JQ, Hickey WF: Human teratomas express differentiated neural antigens. An immunohistochemical study with anti-neurofilament, anti-glial filament, and anti-myelin basic protein monoclonal antibodies. Am J Pathol 1984;115:383-389.
17.
Sabin TD, Jednacz JA, Staats PN, Thomas D: Case 26-2008 - a 26-year-old woman with headache and behavioral changes. N Engl J Med 2008;359:842-853.
18.
Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y: Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 2011;77:589-593.
19.
Dabner M, McCluggage WG, Bundell C, Carr A, Leung Y, Sharma R, Stewart CJ: Ovarian teratoma associated with anti-N-methyl-D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol 2012;31:429-437.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.